Trailing-twelve-month (TTM) revenue is $1.47 Billion with a year-over-year growth of +11.39%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $354,018,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $365,806,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-26 |
| Q1 FY2026Period ended 2026-03-31 | $369,442,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $383,726,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $1,472,992,000 |
Current P/S: $1,407,755,694 market capitalization ÷ $1,472,992,000 TTM revenue = 0.96x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $383.73M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:09:20.152Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2023-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20172017-12-31 · USD | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD |
|---|---|---|---|---|---|---|
| Property And Casualty | N/A | N/A | N/A | $1.1B | $952M | $1.0B |
| Property, Liability and Casualty Insurance Product Line | $997M | $1.0B |
$1.47B
$1.47 Billion
+11.39%
vs. $1.32B a year ago (TTM)
+5.12%
5 Year compound annual growth rate
1 Year
+11.39%
3 Year
+11.66%
5 Year
+5.12%
10 Year
+3.13%
15 Year
+5.89%
20 Year
+4.41%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $1.39B | +$134.55M | +10.75% |
| 2024 | $1.25B | +$153.53M | +13.98% |
| 2023 | $1.10B | +$110.11M | +11.14% |
| 2022 | $988.22M | ($68.28M) | (6.46%) |
| 2021 | $1.06B | ($21.77M) | (2.02%) |
| 2020 |
TTM Growth
+11.39%
3-Year CAGR
+11.66%
5-Year CAGR
+5.12%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $1.1B |
| N/A |
| N/A |
| N/A |
| $1.08B |
| ($121.79M) |
| (10.15%) |
| 2019 | $1.20B | +$119.77M | +11.09% |
| 2018 | $1.08B | +$24.73M | +2.34% |
| 2017 | $1.06B | +$69.36M | +7.03% |
| 2016 | $986.18M | +$89.23M | +9.95% |
